Aromatase and Breast Cancer: W39R, an Inactive Protein

European Journal of Endocrinology - United Kingdom
doi 10.1530/eje.0.1460583
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Bioscientifica

Related search

Guidelines for Osteoprotection in Breast Cancer Patients on an Aromatase Inhibitor

Breast Care
SurgeryOncology
2010English

Genetic Variants of CYP19 (Aromatase) and Breast Cancer Risk

Oncogene
Cancer ResearchGeneticsMolecular Biology
2000English

Aromatase Explains Why Testosterone Increases Breast Cancer Rate

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2009English

Aromatase and COX in Breast Cancer: Enzyme Inhibitors and Beyond

Journal of Steroid Biochemistry and Molecular Biology
Molecular MedicineCell BiologyMolecular BiologyBiochemistryEndocrinologyClinical BiochemistryMetabolismDiabetes
2007English

Autoimmune Hepatitis Deteriorated by Anastrozole, an Aromatase Inhibitor, for Breast Cancer Adjuvant Chemotherapy

Acta Hepatologica Japonica
Hepatology
2014English

Profiles of miRNAs Matched to Biology in Aromatase Inhibitor Resistant Breast Cancer

Oncotarget
Oncology
2016English

The Aromatase Inhibitors as Adjuvant Therapy for Hormone Receptor-Positive Breast Cancer

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2003English

Periodontal Health in Breast Cancer Patients on Aromatase Inhibitorsversuspostmenopausal Controls: A Longitudinal Analysis

Journal of Clinical Periodontology
Periodontics
2016English

Forskolin Increases the Effect of Everolimus on Aromatase Inhibitor-Resistant Breast Cancer Cells

Oncotarget
Oncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy